Skip to main content

TV 2134 Pill - purple capsule/oblong, 16mm

Pill with imprint TV 2134 is Purple, Capsule/Oblong and has been identified as Minocycline Hydrochloride Extended-Release 65 mg. It is supplied by Teva Pharmaceuticals USA, Inc.

Minocycline is used in the treatment of Bacterial Infection; Acne; Bartonellosis; Bullous Pemphigoid; Actinomycosis and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 65 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TV 2134

Minocycline hydrochloride extended-release 65 mg TV 2134

Minocycline Hydrochloride Extended-Release

Imprint
TV 2134
Strength
65 mg
Color
Purple
Size
16.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Tetracyclines
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
00093-2134 (Discontinued)
Inactive Ingredients
carnauba wax, silicon dioxide, hypromellose 2910 (6 mPa.s), lactose monohydrate, magnesium stearate, polyethylene glycol 3350, polyethylene glycol 4000, titanium dioxide, triacetin, D&C Red No. 27, aluminum oxide, FD&C Blue No. 2, indigotindisulfonate sodium, FD&C Red No. 40

Note: Inactive ingredients may vary.

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer